SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XNVAY or XEN
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
28 0 0 XNVAY
Emcee:  Tom Type:  Unmoderated
Introduction Market Data Compact
XNVAY or XEN

I have been watching XENOVA Ltd, the pharmaceutical company in UK.
They have been public at NASDAQ ADR stock market as XNVAY.
And recently they have listed at London Stock Exchange as XEN.

Two days ago XEN was 225 pences, yesterday it was 240, today 267.5 !
Besides, the offer (ask) is 272 pences.
But ! XENOVA have been keeping $3 3/4. Why ?
As you can see DLVRY and COR, NASDAQ usually follows the London market.

If I bought XENOVA's stock, which is better XNVAY or XEN ?

An US analyst (Cowen's ?) published the report in last year,
he rated XNVAY as buy, and the targer max price was $12.

Tom
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
28 Anyone still following this. What a dog, right now. Any insight as to why it&Michael de Haan-7/10/1998
27 WLA & Xenova ! biz.yahoo.comKeiko-3/23/1998
26 Xenova Shares Jump On Research Alliance With Eli Lilly By Erik Portanger LONpat w.-2/19/1998
25 This is great news and I have started a position in the stock today based on itJoe Senesac-2/18/1998
24 Lilly Teams With Xenova Group to Develop Novel Antithrombotic Drugs For Chronicpat w.-2/18/1998
23 Jim, The UK biotech sector is severely depressed. As you know the Celltech sepJames Reynolds-7/21/1997
22 James, Still following although no longer an owner as I sold out a few months James Silverman-7/20/1997
21 Anyone still following this great little company? The current market cap looks James Reynolds-7/20/1997
20 Xenova sounds better and better. Xenova Publishes Data on Novel Low Molecular Michael de Haan-4/8/1997
19 > Mike, I could not access the web site without your passworMichael de Haan-3/20/1997
18 Mike: Assume the reference is to today's news. Here's a clip... At leaDave K-3/20/1997
17 To all, Nice move today. Not sure if this is accessible to all, but give it a Michael de Haan-3/19/1997
16 Thanks for the news update. It's a keeper. DaveDave K-3/7/1997
15 LONDON, March 3 (Reuter) - Shares in drug discovery group Xenova Group Plc roseMichael de Haan-3/7/1997
14 Tom, did not know about the Cowen report. Thanks. $10 in a year would be nice.Dave K-2/12/1997
13 Thanks for the info Tom, I was not aware of Cowen's coverage. In the US tJames Silverman-2/12/1997
12 Dave, You may know that Cowen published several biotechnology companies reportTom-2/12/1997
11 Mike, You are probably right that it will take some time for the potential to James Silverman-1/30/1997
10 Mike, it depends what you mean by "move soon" (its' already movedDave K-1/30/1997
9 My knowledge of Nesbit is through a personal aquaintance - who himself is a rekMichael de Haan-1/30/1997
8 Jim, Don't mean to butt in. Just wanted to add that Dr Ross was a founder Dave K-1/28/1997
7 Michael, Its not much of an analysis, admittedly I bought shares largely on spJames Silverman-1/28/1997
6 Nice analysis, James. I wish I could say I had done as nice an analysis as youMichael de Haan-1/28/1997
5 From what I have seen two keys are: 1. The MDR drugs they have in clinicals neJames Silverman-1/28/1997
4 Dave, I have held xenova for about 3 yrs now. Bought in at 8 but have been buyMichael de Haan-1/28/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News